WTA Requires SRY Gene Testing for Female Athletes
L'essentiel
- The Women's Tennis Association (WTA) has mandated SRY gene testing for female athletes via mouth swab to determine eligibility, with refusal or positive results leading to disciplinary action or temporary suspension.
- This follows an International Olympic Committee (IOC) decision in March 2026 to ban transgender athletes from women's events.
Résumé généré par IA
Pourquoi c'est important
The Women's Tennis Association has introduced a new requirement for female athletes to undergo SRY gene testing, following a decision by the International Olympic Committee in March 2026 to ban transgender athletes from women's events.
MOSCOW, July 20. /TASS/. The Women's Tennis Association (WTA) has required female athletes to undergo gender testing for the presence of the SRY gene, which is associated with male-type biological development, journalist Ben Rothenberg reported on X.
According to the reporter, the test requires a mouth swab. If the gene is absent, an athlete will be allowed to compete in WTA-sanctioned tournaments. If the result is positive, the tennis player will be temporarily suspended pending additional medical examination.
Under the new document, which all athletes are required to sign, refusal to undergo testing may result in disciplinary action by the association.
In March 2026, the International Olympic Committee decided to ban transgender athletes (the LGBT movement is recognized as extremist and banned in Russia) from competing in women's events.
Questions ouvertes
- How will the WTA enforce the testing?
- What are the specific medical examination procedures?
- What are the long-term implications for athletes?
